Literature DB >> 9382010

Doppler evaluation of aortic regurgitation in children.

L Y Tani1, L L Minich, R W Day, G S Orsmond, R E Shaddy.   

Abstract

Doppler indexes have been used successfully to determine the severity of aortic regurgitation (AR) in adults but have not been evaluated systematically in children. To evaluate the accuracy of specific Doppler echocardiographic indexes in assessing the degree of AR in children, 30 children underwent 2-dimensional and Doppler echocardiography within 24 hours of angiography. Patients were divided into 4 groups based on the degree of angiographic AR. Color Doppler jet width, short-axis jet area, jet length, and maximum jet area were measured. AR slope was measured using continuous-wave Doppler. Flow in the abdominal aorta was evaluated using pulsed Doppler. Doppler indexes were compared with the angiographic grade of AR. Jet width and short-axis jet area were significantly different between groups and showed strong correlation with the angiographic grade. Holodiastolic flow reversal in the abdominal aorta separated 1+ to 2+ from 3+ to 4+ AR (100% sensitivity and 100% negative predictive value for 3+ to 4+ AR). Jet length, maximum jet area, and the ratio of reverse to forward abdominal aortic velocity time integrals correlated with angiography but showed little difference between groups that differed by only 1 angiographic grade. AR slope did not correlate with the angiographic grade. We conclude that in children, color Doppler jet width, short-axis jet area, and holodiastolic abdominal aortic flow reversal are the best predictors of angiographic severity. Use of these indexes may obviate the need for angiography to determine the degree of AR in children.

Entities:  

Mesh:

Year:  1997        PMID: 9382010     DOI: 10.1016/s0002-9149(97)00547-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Assessment of cardiac function and rheumatic heart disease in children with adenotonsillar hypertrophy.

Authors:  Ender Odemis; Ferhat Catal; Ahmet Karadag; Hanifi Kurtaran; Nebil Ark; Emin Mete
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

Review 2.  Surgical and physiological challenges in the development of left and right heart failure in rat models.

Authors:  Michael G Katz; Anthony S Fargnoli; Sarah M Gubara; Elena Chepurko; Charles R Bridges; Roger J Hajjar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

3.  Evaluation of subvalvular aortic stenosis in children: a 16-year single-center experience.

Authors:  Fahrettin Uysal; Ozlem Mehtap Bostan; Isik Senkaya Signak; Evren Semizel; Ergun Cil
Journal:  Pediatr Cardiol       Date:  2013-03-02       Impact factor: 1.655

4.  Repair of incompetent truncal valves: early and mid-term results.

Authors:  Gianluigi Perri; Sergio Filippelli; Angelo Polito; Duccio Di Carlo; Sonia B Albanese; Adriano Carotti
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-13

5.  Management of valvar aortic stenosis in children.

Authors:  J D R Thomson
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

6.  Holodiastolic Flow Reversal at the Descending Aorta on Cardiac Magnetic Resonance is Neither Sensitive Nor Specific for Significant Aortic Regurgitation in Patients with Congenital Heart Disease.

Authors:  Catherine M Avitabile; Kevin K Whitehead; Mark A Fogel; Daniel W Kim; Timothy S Kim; Julian D Rose; Marc S Keller; Gregory L Fu; Matthew A Harris
Journal:  Pediatr Cardiol       Date:  2016-06-16       Impact factor: 1.655

7.  Mid- and Longterm Neo-Aortic Valve Regurgitation after Jatene Surgery: Prevalence and Risk Factors.

Authors:  Cristiane Nunes Martins; Bayard Gontijo Filho; Roberto Max Lopes; Francisco das Chagas Lima E Silva
Journal:  Arq Bras Cardiol       Date:  2018-07-02       Impact factor: 2.000

8.  Early and mid-term follow-up of patients receiving arterial switch operation: a single-center experience.

Authors:  Yaqiong Xiao; Ping Zhang; Wei Su; Nianguo Dong
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.